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ABSTRACT
MMsINC (http://mms.dsfarm.unipd.it/MMsINC/
search) is a database of non-redundant, richly anno-
tated and biomedically relevant chemical structures.
A primary goal of MMsINC is to guarantee the
highest quality and the uniqueness of each entry.
MMsINC then adds value to these entries by includ-
ing the analysis of crucial chemical properties, such
as ionization and tautomerization processes, and
the in silico prediction of 24 important molecular
properties in the biochemical profile of each struc-
ture. MMsINC is consequently a natural input for
different chemoinformatics and virtual screening
applications. In addition, MMsINC supports various
types of queries, including substructure queries and
the novel ‘molecular scissoring’ query. MMsINC is
interfaced with other primary data collectors, such
as PubChem, Protein Data Bank (PDB), the Food
and Drug Administration database of approved
drugs and ZINC.
INTRODUCTION
One of the most important issues in the post-proteomic
era is relating protein pharmacology by ligand chemistry
(1). In fact, there is intriguing pharmacological evidence
that related drugs can recognize molecular targets that
appear unrelated by many bioinformatics metrics (1).
Drug side eﬀects and related toxicity proﬁles can be con-
sidered the obvious consequence of this polypharmacol-
ogy. The capability of chemically related drugs to bind
proteins without sequence or structure similarity can
limit attempts in bioinformatics to understand and cate-
gorize their pharmacological action. On the other hand, a
chemo-centric approach to this problem compares not
only the biological targets themselves, but also the chem-
istry involving their ligands (1,2).
We have planned MMsINC with this chemo-centric
approach in mind, integrating chemical structures, their
chemical behaviour annotations and purpose-speciﬁc
search functions, with the aim of creating a valuable
tool for the interpretation of protein pharmacology
(including toxicology) by ligand chemistry. (If you refer
to MMsINC database and web interface for your pub-
lished research, we ask that you please cite this article.)
Like others, from a chemoinformatics point of view
MMsINC is a chemical structure database, where chemi-
cals are appropriately stored and annotated. However,
MMsINC has as its main priorities to eliminate redun-
dancy in its data, and to guarantee the accuracy of all
chemical annotations derived from a chemical structure
to avoid chemical misleading. An accurate chemical anno-
tation is also crucial for the signiﬁcance of any qualitative
or quantitative chemical similarity metrics, which are a
key principle in ligand/drug design and a good guide to
the biological comparison of chemicals (3). Indeed, struc-
ture- and property-based similarities are useful tools
implemented by MMsINC with the goal to establish
chemical connections among all MMsINC entries and
other publicly available databases (PDB (4), PubChem
(5), DrugBank (6), ZINC (7) and ChemDB (8), among
others). We also apply MMsINC’s structure-based anno-
tation and similarity to classify all MMsINC entries into
sets of several biologically relevant targets based on their
fragment-driven similarity score. MMsINC is conse-
quently a natural input for diﬀerent chemoinformatics
and virtual screening applications, and its integration
with well-consolidated virtual screening tools, such as
pharmacophore screening and molecular docking is in
progress (Table 1).
All of MMsINC’s data and functions are accessible
through a user-friendly web interface that we describe
later in this text.
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MMsINC is a public, web-based informatics platform
derived from the aggregation and multi-step treatment of
46 data sources: primarily commercial vendor catalogues,
but also of publicly available repositories (e.g. NCI, http://
cactus.nci.nih.gov). For sources that periodically update
their data and make them available on the Internet, we
automatically download the data and synchronize
MMsINC with the latest version. Complete information
about all the vendors is available in the Supplementary
Materials. In total, the current database contains about 4
million unique compounds, resulting from the distillation
of the original set of 7.5 million entries (Table 2).
The objective of our treatment process is to generate a
data set that is free of redundancy and with a chemical
orthography that is as accurate as possible. In addition,
we calculate the most probable tautomeric and ionic states
at physiological conditions, and we produce one possible
stable conformer for each molecular entry. These are the
steps we follow to assemble the MMsINC data set.
Step 1: first redundancy washing. Using the Molecular
Operating Environment software suite (MOE, version
2007.09, http://www.chemcomp.com), we remove all ori-
ginally redundant entries based on their SMILES (9)
representation, reducing the number of entries from
7.5M to 4M.
Step 2: generation of tautomers. We apply the LigPrep 2.1
tool by Schro ¨ dinger LLC (http://www.schrodinger.com/)
to generate the tautomers for each molecule resulting from
Step 1. Many of the tautomers we generate at this stage
are unstable molecules, and therefore unlikely to be
encountered in practice. These will be eliminated later in
our process. In the meantime, we add all the generated
tautomers to our data set.
Step 3: generation of ionic states. By ionic states, we refer
to the most energetically favourable electrically charged
states that a molecule can assume at a pH of 7.4. We
calculate the most favourable ionic states for each mole-
cular entry resulting from Step 2 by using the ‘Protonate’
tool in the MOE suite. The calculations add a further
250000 MMsINC entries.
Step 4: conformer selection. The three-dimensional (3D)
structure of each MMsINC entry (including all tautomers
and ionic states) is calculated by using Corina 3.4 (http://
www.mol-net.de). For each input structure, Corina gener-
ates possible conformers, which are variations of the mole-
cule where the existing bonds are the same, but parts of
the molecule are rotated diﬀerently along these bonds. The
software then selects one of the lowest energy conformers
generated. We use Corina with its default conﬁguration.
Step 5: second redundancy washing. The SMILES encod-
ing used for the ﬁrst redundancy washing is ambiguous,
making it possible for some molecular redundancy to slip
through Step 1. In addition, it is possible for Steps 2 and 3
to generate identical structures. We therefore perform a
second, InChI-based (10), redundancy washing that elim-
inates any such duplicates and achieves our goal of struc-
tural uniqueness in the database.
Step 6: unstable tautomer elimination. To eliminate the
unstable tautomers generated in Step 2, we determine
their energy stability with a force ﬁeld-based criterion
using the 3D structural data calculated in Step 4. For
each ‘parent’ neutral molecule, we then keep in our data
set only the most stable tautomers, up to a maximum of
ﬁve. Instead, the less stable tautomers are discarded. The
calculations leave us with  1.1M tautomers that become
part of the MMsINC data set.
The result of these steps is a non-redundant data set of
neutral molecular structures, as well as their stable tauto-
mers and ionic states.
Molecular descriptors
For the molecules resulting from the data set building
process, we calculate 24 molecular properties useful
for quantitative structure–activity relationship (QSAR),
diversity analysis or combinatorial library design. We
assign the corresponding partial charges to all atoms of
each unique conformer by using the MMFF94 force ﬁeld
algorithm implemented by MOE. All other descriptors
summarized in Table 3 are calculated using the MOE
tool ‘QSAR-Descriptor’. For a detailed explanation of
the descriptors, please refer to the MMsINC help pages
accessible via Internet.
Table 1. Comparison of MMsINC with other publicly available molec-
ular databases (Y=available)
ZINC ChemBank PubChem ChemDB MMsINC
Features
Full download Y Y
a YY
Subset download Y Y
a YY Y
Size 8M 1.7M 19.6M 5M 4M
Non-redundant
(InChI-based)
Y
Chirality Y Y Y Y
FDA similarities Y
PDB ligand
similarities
Y
Link to PDB Y Y Y
Link to PubChem N/A Y Y
Search
By exact structure Y Y Y
By similarity Y Y Y Y
By substructure Y Y Y Y Y
By fragment Y
By molecular
descriptors
YY Y Y Y
By assays Y Y
aOnly for registered users.
Table 2. MMsINC Database statistics. Drug- and lead-likeness have
been measured by Lipinski (11) and Oprea (12) criteria
Frameworks more than 175,000
Drug-like molecules 3.89 million (98%)
Lead-like molecules 3.61 million (91%)
Chemically stable compounds 3.45 million (87%)
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The MMsINC database is accessible to the public via
our web application. It allows users to search the database
by structural criteria, either by specifying a structure by
one of the standard notations (SMILES, InChI, standard
molecular formula), by drawing it with the Java Molecular
Editor (JME, by Peter Ertl, http://www.molinspiration.
com/jme/) or by identifying a structure in the MMsINC
database by its MMsCode—our database’s unique molec-
ular identiﬁer. The application also allows users to ﬁnd
MMsINC molecules by similarity to PDB Ligands (4),
which in turn are selected by similarity to a query struc-
ture. In the following sections, we describe these diﬀerent
structure and similarity search methods supported by
MMsINC.
Identical structure search
The identical structure search allows the user to search for
molecules that match the structure speciﬁed by the query.
MMsCode and InChI queries will result in at most one
result, since they are unambiguous. On the other hand,
SMILES and molecular formulas are ambiguous, so the
search will return all molecules represented by the query
found in MMsINC.
Substructuresearch
The substructure search is a query that allows the user
to ﬁnd molecules that contain a substructure of interest.
The user speciﬁes the substructure as a SMILES string or
as an MMsCode which identiﬁes a structure known to
MMsINC.
The query is executed using structural keys, which are
bit vectors that indicate with a ‘1’ the presence of a par-
ticular structural feature, and with a ‘0’ its absence.
MMsINC uses 643-bit structural keys that identify a
subset of the structures in the PubChem (5) ﬁngerprints.
If the query is speciﬁed as a SMILES string, MMsINC
generates a query structural key dynamically. On the other
hand, if the query is an MMsCode the system fetches the
precalculated structural key associated with the identiﬁed
molecule. The query key is then compared with the struc-
tural keys of the molecules in MMsINC, and the mole-
cules that contain all the structural bits of the query are
retrieved. This method provides a rapid and eﬀective
screening of the database, but its results can include
false positives, since the key may not completely describe
the query structure. Therefore, these preliminary results
are ﬁltered by an exact subgraph containment check
using the Chemistry Development Kit (CDK) library (13).
In some cases the preliminary key search results in too
many molecules to perform the subgraph containment
check on all the molecules in a reasonable amount of
time. In these cases, MMsINC only performs the sub-
graph isomorphism check on the molecules as they are
displayed to the user, indicating whether they are false
positives. Currently this behaviour is applied only if the
structural key search results in more than 30000 results
(Figure 1).
Molecular scissoring search
The molecular scissoring search is a novel type of query
based on chemically relevant molecular fragments known
as scaﬀolds. The user provides a query structure, as in the
substructure search described in the previous section. The
system identiﬁes the scaﬀolds present in the query struc-
ture, and asks the user to specify which ones to use for the
search, and whether to perform an ‘and’ query searching
for the molecules that contain all the selected scaﬀolds, or
an ‘or’ query searching for the molecules that contain any
of the selected scaﬀolds. The query is then sent to the
database where it is evaluated with the help of appropriate
indices over the scaﬀold data.
Our current implementation of the scissoring search can
in some rare cases allow the user to select scaﬀolds that do
not exist in the query molecule. We know about this issue
and are already working to resolve it. However, we do not
believe it is serious enough to justify disabling the scissor-
ing query in MMsINC. This query type is important
because it allows chemists to easily and quickly search
for molecules that contain particular chemical substruc-
tures that are known to be chemically and/or pharmaco-
logically relevant (Figure 2).
Similarity search
The similarity search is a query type that retrieves all mole-
cules in MMsINC that are structurally similar to query
molecule. We measure the similarity between structures
using the Tanimoto similarity score (3) on the structural
keys describing them. The Tanimoto similarity is deﬁned
as the ratio of the number of bits set to ‘1’ in both keys to
the number of bits set to ‘1’ in either of the two keys. For
two structural keys A, B we have:
TðA,BÞ¼
jA \ Bj
jA [ Bj
To perform a similarity search, the user enters a query
structure and speciﬁes a minimum acceptable similarity
score. MMsINC compares the precalculated structural
keys of its molecules with the structural key of the query
and returns all the molecules with a Tanimoto similarity
greater than or equal to the threshold.
To accelerate Tanimoto similarity searches, we have
implemented the technique by Swamidass and Baldi
(14). Their result allows us to bound the number of ones
in the target structural key required to achieve a similarity
score that meets the threshold, considerably reducing the
Table 3. MMsINC molecular descriptors
Descriptor Category Descriptors
Physical Molecular weight, reactive groups,
SlogP, logS
Topological Globularity, Sterimol/B1-4/L
Surface and Volume ASA/+/ /H, Volume
Pharmacophoric HB donor, HB acceptor, acid and
basic groups, chiral centers
Energetic Potential energy
Drug candidacy Lipinski drug-like, Oprea lead-like
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Figure 1. MMsINC’s substructure search screen.
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late the Tanimoto similarity. The fraction of the database
that is pruned from the search by using this technique
varies from 30% to 100%.
Filtering by descriptors
As a supplement to the more sophisticated structural
query methods just described, MMsINC users can further
ﬁlter their search results (except when performing the
identical structure search) by the molecular descriptors
that MMsINC provides for each molecule in the database.
Displaying structural queryresults
Results from a structural query are displayed in pages of
up to 20 molecules. For each result, the system displays
the structural diagram of the molecule and its MMsCode.
Users can select results that interest them and place them
in the MMsINC ‘cart’ as they browse through the search
results. The cart can then be saved locally to a standard
SDF ﬁle.
Clicking on a molecule from the results list takes the
user to the molecule report for the speciﬁc selection
(Figure 3). The report shows the user basic information
about the molecule like the compound type (neutral, tau-
tomer or ionic state), the molecular formula and its InChI
and SMILES representations. The report also contains a
2D image of the molecule, and a 3D-movable rendering of
molecule shown using Chemis3D (http://chemis.free.fr/
mol3d/) Java applet. In addition, the precalculated
descriptors for the molecule are listed at the bottom of
the report. Finally, for neutral molecules the system lists
all its tautomers and ions, while for tautomers and ions
the neutral state of the molecule is indicated.
From the molecule’s report page the user can download
the structural and descriptor data to his or her own com-
puter in several standardized formats, including SDF,
PDB, XYZ, as well as 2D and 3D MOLFILE. The user
can also retrieve the list of the PDB ligands that are simi-
lar to the molecule, as well as retrieving a list of structur-
ally similar FDA-approved drugs. Finally, the report has
links to the PubChem and ZINC entries for the molecule.
Figure 3. Report for molecule MMs03214909.
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An alternative method to query MMsINC is via similarity
to PDB ligands that have been inserted into our database.
This search type has two modes of operation: SMILES
and PDB. In the ﬁrst mode, the user provides a molecular
structure as a query, and a minimum threshold for
the Tanimoto similarity measure. MMsINC ﬁnds PDB
ligands with a Tanimoto similarity to the query structure
greater than or equal to the speciﬁed threshold. In the
second mode, the user speciﬁes a list of up to ﬁve PDB
protein identiﬁers. MMsINC ﬁnds all the ligands for the
identiﬁed PDB proteins. In either case, MMsINC presents
to the user the identiﬁed PDB ligands, with their structural
diagram and the ligand code. Selecting a speciﬁc ligand
takes the user to the ligand report page.
The ligand report page summarizes all the MMsINC
neutral molecules, tautomers, ionic states and FDA-
approved drugs that are similar to the ligand, with a
Tanimoto similarity score threshold speciﬁed by the user
but  0.70 (Figure 4). Clicking on any of these molecules
takes the user to the molecule’s report page. The ligand
report page also contains basic information about the
ligand, such as its 2D structural diagram, its three-letter
code and its name, and a table showing all the PDB pro-
teins that interact with this ligand is displayed with a click.
The PDB ligand search is based on the complete set of
ligands from the PDB Chemical Component Dictionary
(CCD). The MMsINC database integrates the version of
the PDB CCD retrieved on January 31, 2008. However, it
should be noted that not all of these PDB ligands used by
the query mechanism are included in the main MMsINC
data.
Implementation
The MMsINC system uses the PostgreSQL RDBMS
(http://www.postgresql.org) to manage its data. The data-
base is installed on a server running Linux.
The system’s web application has been developed in
PHP, with some components written in Java. MMsINC
uses the CDK to perform some of its molecular analyses.
CONCLUSION
The MMsINC database has been created to support a
chemo-centric approach to relate protein pharmacology
by ligand chemistry. The primary aims of this growing
database are the accuracy of all chemical information
and the elimination of redundant data. In addition,
MMsINC is naturally predisposed to integrate chemical,
biological and pharmacological information coming from
Figure 4. The results page from an MMsINC query.
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novel molecule query functions make it a new tool for
chemoinformaticians. The integration with consolidated
virtual screening tools, such as pharmacophore screening
and molecular docking, will be available in the next release
of MMsINC.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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